| [1] | GBD 2019 Under-5 Mortality Collaborators. (2021). Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: All-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet (London, England) 398 : 870-905. DOI: 10.1016/S0140-6736(21)01207-1. |
| [2] | Zou, X.H. and Cao, B. (2022). Advances in pathogen diagnosis of respiratory infection diseases in 2021. Chinese Journal of Tuberculosis and Respiratory Diseases 45: 78−82. DOI: 10.3760/cma.j.cn112147-20211116-00809. |
| [3] | Bosch de Basea Gomez, M., hierry-Chef, I., Harbron, R., et al. (2023). Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat. Med. 29: 3111−3119. DOI: 10.1038/s41591-023-02620-0. |
| [4] | Kampmann, B., Madhi, S.A., Munjal, I., et al. (2023). Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N. Engl. J. Med. 388: 1451−1464. DOI: 10.1056/NEJMoa2216480. |
| [5] | Xu, B.P., Li, X.M., Hu, S.Y., et al. (2022). Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial. Pediatr. Investig. 6: 75−84. DOI: 10.1002/ped4.12326. |
| Yin J. and Xu B. (2024). Diagnosis, treatment, and prevention of lower respiratory tract infections in children. The Innovation Medicine 2(1): 100060. https://doi.org/10.59717/j.xinn-med.2024.100060 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Diagnosis, treatment, and prevention of lower respiratory tract infections in children.